Innovative Reflux Detection Device In Practice

Dr. Michael Mahdavi is among the early adopters of a new wireless technology that detects acidic reflux in the airway. The Restech Dx-pH Measurement System received nationwide acclaim for its clinical significance, delivering clear insight into a rising incidence of reflux-related disorders.

Laryngopharyngeal reflux disease (LPRD) is known in medical circles as a “silent disease.” It is difficult to detect because conventional pH measurement systems cannot function properly above the esophagus due to sensor dry-out. The Restech Dx-pH Probe incorporates the first and only pH sensor capable of self-condensing, thus facilitating reliable measurement and recording of aerosolized reflux in the upper airway.Like scores of other physicians around the country, Dr. Mahdavi turned to the Restech Dx-System not only to detect a stealthy and common disease state, but also to gauge the effectiveness of empirically prescribed Proton Pump Inhibitor (PPI) therapy (Nexium, AcipHex, Prilosec).A recent meta-analysis of empiric treatment of LPR with PPI trials, published by Karkos and Wilson (Laryngoscope), concluded that “the few randomized, controlled trials have failed to demonstrate superiority of PPIs over placebo for treatment of suspected LPR.” This new evidence is making some doctors think twice before prescribing PPIs without a positive pH study.(Source: University of San Diego : June 2007.)